Cargando…
Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea
Fecal microbiota transplantation (FMT) is a highly efficacious and safe modality for the treatment of recurrent or refractory Clostridioides difficile infection (CDI), with overall success rates of 90%. Thus, FMT has been widely used for 10 years. The incidence and clinical characteristics of CDI, t...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Neurogastroenterology and Motility
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748844/ https://www.ncbi.nlm.nih.gov/pubmed/34980687 http://dx.doi.org/10.5056/jnm21221 |
_version_ | 1784631097003343872 |
---|---|
author | Gweon, Tae-Geun Lee, Yoo Jin Kim, Kyeong Ok Yim, Sung Kyun Soh, Jae Seung Kim, Seung Young Park, Jae Jun Shin, Seung Yong Lee, Tae Hee Choi, Chang Hwan Cho, Young-Seok Yong, Dongeun Chung, Jin-Won Lee, Kwang Jae Lee, Oh Young Choi, Myung-Gyu Choi, Miyoung |
author_facet | Gweon, Tae-Geun Lee, Yoo Jin Kim, Kyeong Ok Yim, Sung Kyun Soh, Jae Seung Kim, Seung Young Park, Jae Jun Shin, Seung Yong Lee, Tae Hee Choi, Chang Hwan Cho, Young-Seok Yong, Dongeun Chung, Jin-Won Lee, Kwang Jae Lee, Oh Young Choi, Myung-Gyu Choi, Miyoung |
author_sort | Gweon, Tae-Geun |
collection | PubMed |
description | Fecal microbiota transplantation (FMT) is a highly efficacious and safe modality for the treatment of recurrent or refractory Clostridioides difficile infection (CDI), with overall success rates of 90%. Thus, FMT has been widely used for 10 years. The incidence and clinical characteristics of CDI, the main indication for FMT, differ between countries. To date, several guidelines have been published. However, most of them were published in Western countries and therefore cannot represent the Korean national healthcare systems. One of the barriers to performing FMT is a lack of national guidelines. Accordingly, multidisciplinary experts in this field have developed practical guidelines for FMT. The purpose of these guidelines is to aid physicians performing FMT, which can be adapted to treat CDI and other conditions. |
format | Online Article Text |
id | pubmed-8748844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Korean Society of Neurogastroenterology and Motility |
record_format | MEDLINE/PubMed |
spelling | pubmed-87488442022-01-30 Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea Gweon, Tae-Geun Lee, Yoo Jin Kim, Kyeong Ok Yim, Sung Kyun Soh, Jae Seung Kim, Seung Young Park, Jae Jun Shin, Seung Yong Lee, Tae Hee Choi, Chang Hwan Cho, Young-Seok Yong, Dongeun Chung, Jin-Won Lee, Kwang Jae Lee, Oh Young Choi, Myung-Gyu Choi, Miyoung J Neurogastroenterol Motil Review Fecal microbiota transplantation (FMT) is a highly efficacious and safe modality for the treatment of recurrent or refractory Clostridioides difficile infection (CDI), with overall success rates of 90%. Thus, FMT has been widely used for 10 years. The incidence and clinical characteristics of CDI, the main indication for FMT, differ between countries. To date, several guidelines have been published. However, most of them were published in Western countries and therefore cannot represent the Korean national healthcare systems. One of the barriers to performing FMT is a lack of national guidelines. Accordingly, multidisciplinary experts in this field have developed practical guidelines for FMT. The purpose of these guidelines is to aid physicians performing FMT, which can be adapted to treat CDI and other conditions. The Korean Society of Neurogastroenterology and Motility 2022-01-30 2022-01-30 /pmc/articles/PMC8748844/ /pubmed/34980687 http://dx.doi.org/10.5056/jnm21221 Text en © 2022 The Korean Society of Neurogastroenterology and Motility https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Gweon, Tae-Geun Lee, Yoo Jin Kim, Kyeong Ok Yim, Sung Kyun Soh, Jae Seung Kim, Seung Young Park, Jae Jun Shin, Seung Yong Lee, Tae Hee Choi, Chang Hwan Cho, Young-Seok Yong, Dongeun Chung, Jin-Won Lee, Kwang Jae Lee, Oh Young Choi, Myung-Gyu Choi, Miyoung Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea |
title | Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea |
title_full | Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea |
title_fullStr | Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea |
title_full_unstemmed | Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea |
title_short | Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea |
title_sort | clinical practice guidelines for fecal microbiota transplantation in korea |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748844/ https://www.ncbi.nlm.nih.gov/pubmed/34980687 http://dx.doi.org/10.5056/jnm21221 |
work_keys_str_mv | AT gweontaegeun clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT leeyoojin clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT kimkyeongok clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT yimsungkyun clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT sohjaeseung clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT kimseungyoung clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT parkjaejun clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT shinseungyong clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT leetaehee clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT choichanghwan clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT choyoungseok clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT yongdongeun clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT chungjinwon clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT leekwangjae clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT leeohyoung clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT choimyunggyu clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT choimiyoung clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea AT clinicalpracticeguidelinesforfecalmicrobiotatransplantationinkorea |